Sectors & Industries HealthcareDrug Manufacturers - Specialty & Generic
Best Pharmaceutical Stocks to Buy Now (2025)
Top pharmaceutical stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best pharmaceutical stocks to buy now. Learn More.

Industry: Drug Manufacturers - Spec...

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Pharmaceutical is Zen Rated B and is the 30th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
IRWD	IRONWOOD PHARMACEUTICALS INC	$582.39M	-9.50%	8.10%	82.93%	18.10%	-2.50	1.13	100.00%	8.40%	37.56%
COLL	COLLEGIUM PHARMACEUTICAL INC	$1.54B	24.10%	3.60%	14.43%	18.70%	4.85	1.36	57.20%	7.70%	22.00%
INDV	INDIVIOR PLC	$4.44B	-69.60%	11.60%	65.63%	86.80%	-7.84	0.96	82.90%	14.10%	25.06%
PAHC	PHIBRO ANIMAL HEALTH CORP	$1.63B	24.40%	5.10%	11.98%	8.10%	3.45	3.09	31.20%	4.80%	9.55%
AMRX	AMNEAL PHARMACEUTICALS INC	$3.84B	-5.10%	0.20%	9.62%	7.20%	-33.89	2.13	36.80%	0.20%	8.98%
BHC	BAUSCH HEALTH COMPANIES INC	$2.56B	-38.20%	1.40%	9.55%	8.30%	-46.85	1.30	70.70%	3.60%	20.99%
ANIP	ANI PHARMACEUTICALS INC	$1.81B	8.80%	2.90%	6.35%	7.60%	1.78	2.58	61.10%	4.70%	8.73%
SUPN	SUPERNUS PHARMACEUTICALS INC	$2.70B	-1.80%	-1.40%	-1.90%	-6.10%	0.35	1.80	88.60%	-2.80%	-3.04%
NBIX	NEUROCRINE BIOSCIENCES INC	$15.24B	15.80%	11.00%	17.33%	18.00%	0.42	3.38	98.40%	16.00%	23.43%
PCRX	PACIRA BIOSCIENCES INC	$1.13B	2.80%	1.40%	5.05%	5.30%	0.78	5.26	79.20%	3.00%	8.38%
ORGO	ORGANOGENESIS HOLDINGS INC	$611.72M	-5.40%	-2.80%	-1.98%	-2.60%	0.49	3.32	74.50%	-2.90%	-1.79%
ELAN	ELANCO ANIMAL HEALTH INC	$10.58B	0.60%	0.30%	1.41%	2.30%	1.01	2.40	55.00%	0.80%	3.70%
KMDA	KAMADA LTD	$403.69M	7.90%	5.50%	6.68%	16.90%	0.42	4.03	43.80%	11.70%	12.58%
VTRS	VIATRIS INC	$13.42B	-22.70%	-9.40%	-11.05%	-15.10%	1.49	1.35	36.00%	-26.10%	-23.91%
EBS	EMERGENT BIOSOLUTIONS INC	$599.25M	14.10%	5.30%	12.48%	12.90%	1.51	5.77	54.50%	9.60%	20.95%
TEVA	TEVA PHARMACEUTICAL INDUSTRIES LTD	$34.18B	11.10%	1.80%	6.63%	8.20%	4.50	1.11	50.10%	4.20%	11.22%
ALKS	ALKERMES PLC	$4.71B	21.40%	15.50%	21.91%	32.80%	0.34	3.67	86.00%	22.30%	26.71%
ASRT	ASSERTIO HOLDINGS INC	$73.34M	-27.00%	-9.90%	-16.91%	-30.60%	2.02	1.58	68.20%	-21.10%	-18.84%
DVAX	DYNAVAX TECHNOLOGIES CORP	$1.27B	-8.10%	-4.60%	-4.04%	-3.30%	0.77	7.62	83.20%	-13.10%	-10.27%
HCM	HUTCHMED (CHINA) LTD	$2.34B	5.10%	3.00%	5.32%	6.30%	0.66	2.83	44.60%	6.00%	7.58%
ETON	ETON PHARMACEUTICALS INC	$447.85M	-27.90%	-7.30%	-4.44%	-8.20%	3.52	1.63	51.90%	-9.40%	-3.77%
ESPR	ESPERION THERAPEUTICS INC	$920.39M	N/A	-30.70%	-550.25%	-5.10%	-1.81	1.00	58.20%	-34.80%	-9.03%
AMPH	AMPHASTAR PHARMACEUTICALS INC	$1.16B	14.80%	6.90%	11.02%	12.20%	1.15	3.12	49.40%	15.40%	22.25%
CTOR	CITIUS ONCOLOGY INC	$88.56M	-68.40%	-29.70%	-65.81%	-52.40%	1.83	0.35	N/A	N/A	N/A
HLN	HALEON PLC	$43.24B	8.80%	4.20%	7.64%	20.40%	1.12	0.98	60.70%	12.80%	19.40%
PRGO	PERRIGO CO PLC	$1.81B	-1.20%	-0.50%	2.73%	4.00%	1.27	2.51	35.50%	-1.20%	5.69%
PBH	PRESTIGE CONSUMER HEALTHCARE INC	$2.95B	11.00%	5.90%	9.90%	23.40%	0.89	3.70	56.10%	18.10%	29.49%
DERM	JOURNEY MEDICAL CORP	$208.13M	-39.90%	-10.50%	-10.88%	-28.40%	2.29	1.42	70.20%	-14.60%	-8.33%
LFCR	LIFECORE BIOMEDICAL INC	$291.86M	N/A	N/A	N/A	N/A	-18.83	2.80	N/A	N/A	N/A
TKNO	ALPHA TEKNOVA INC	$252.12M	-23.50%	-16.20%	-17.39%	-14.80%	0.48	5.27	31.00%	-45.80%	-43.99%
EOLS	EVOLUS INC	$456.33M	N/A	-26.20%	-24.65%	-22.30%	-8.62	2.02	65.80%	-20.50%	-13.13%
ZTS	ZOETIS INC	$52.29B	53.60%	18.30%	26.57%	27.80%	1.81	3.64	71.70%	28.20%	37.75%
SIGA	SIGA TECHNOLOGIES INC	$462.61M	35.30%	31.10%	46.88%	213.10%	0.14	9.17	76.30%	43.20%	56.27%
SCYX	SCYNEXIS INC	$27.11M	-54.30%	-37.40%	-58.43%	-52.10%	0.40	5.75	100.00%	-862.90%	-849.01%
HROW	HARROW INC	$1.74B	-9.00%	-1.40%	6.67%	9.40%	6.73	2.72	74.60%	-2.00%	7.95%
TAK	TAKEDA PHARMACEUTICAL CO LTD	$45.60B	0.50%	0.20%	3.00%	4.50%	1.03	1.37	64.60%	0.70%	8.37%
LNTH	LANTHEUS HOLDINGS INC	$4.42B	14.80%	8.00%	13.60%	22.30%	1.03	2.67	62.20%	11.00%	17.19%
CRON	CRONOS GROUP INC	$1.25B	3.40%	3.10%	-0.57%	-2.60%	0.04	22.46	43.40%	27.30%	-4.88%
RGC	REGENCELL BIOSCIENCE HOLDINGS LTD	$8.21B	-54.80%	-50.50%	-70.39%	-83.50%	0.18	7.39	N/A	N/A	N/A
TLRY	TILRAY BRANDS INC	$1.36B	-93.00%	-73.30%	-123.96%	-196.00%	0.37	2.62	28.70%	-259.10%	-270.82%
RDY	DR REDDYS LABORATORIES LTD	$11.70B	18.40%	12.80%	21.76%	28.70%	0.47	1.92	58.50%	17.40%	24.24%
TLPH	TALPHERA INC	$55.47M	-125.80%	-61.60%	-45.00%	-69.20%	0.60	6.83	100.00%	-44,242.90%	-44,242.86%
CGC	CANOPY GROWTH CORP	$595.42M	-67.00%	-38.00%	-38.91%	-41.30%	0.45	5.50	26.80%	-138.50%	-138.08%
AQST	AQUESTIVE THERAPEUTICS INC	$757.64M	N/A	-59.90%	-37.64%	-38.10%	-40.81	5.93	60.30%	-158.90%	-119.69%
BIOA	BIOAGE LABS INC	$461.81M	-25.10%	-22.80%	-26.68%	-137.60%	0.10	11.87	100.00%	-1,280.90%	-1,265.29%
OGI	ORGANIGRAM GLOBAL INC	$257.32M	2.30%	1.60%	-0.44%	-0.80%	0.47	2.59	33.80%	3.60%	-0.90%
QNTM	QUANTUM BIOPHARMA LTD	$35.80M	-384.90%	-185.60%	-370.55%	-12,582.70%	0.77	1.41	N/A	N/A	N/A
AKAN	AKANDA CORP	$684.54k	-56.60%	-27.50%	-66.04%	-3,415.80%	0.88	1.26	9.60%	-619.50%	-619.14%
FLGC	FLORA GROWTH CORP	$7.22M	-81.60%	-43.90%	-23.97%	-88.40%	0.14	2.08	17.50%	-32.10%	-31.54%
ALVO	ALVOTECH	$1.74B	-26.10%	5.30%	20.46%	10.40%	-8.97	1.42	55.60%	12.10%	39.44%
RMTI	ROCKWELL MEDICAL INC	$36.45M	-16.80%	-9.90%	-9.16%	-13.10%	0.55	3.92	15.10%	-7.30%	-5.81%
KALA	KALA BIO INC	$5.54M	-2,323.90%	-87.00%	414.59%	-230.60%	-3.89	0.75	N/A	N/A	N/A
SHPH	SHUTTLE PHARMACEUTICALS HOLDINGS INC	$2.87M	-476.10%	-253.90%	-674.65%	-20,966.60%	1.54	1.66	N/A	N/A	N/A
ACB	AURORA CANNABIS INC	$303.76M	-13.10%	-8.80%	-8.72%	-10.20%	0.36	3.42	43.90%	-19.80%	-15.03%
CRDL	CARDIOL THERAPEUTICS INC	$94.45M	-218.50%	-154.20%	-360.16%	733.30%	0.35	3.89	N/A	N/A	N/A
ZYBT	ZHENGYE BIOTECHNOLOGY HOLDING LTD	$94.80M	4.10%	2.30%	4.56%	4.10%	0.50	1.31	49.00%	6.10%	8.73%
EVO	EVOTEC SE	$1.07B	-18.10%	-8.50%	-8.37%	-8.40%	1.22	2.12	10.80%	-21.00%	-15.47%
APUS	APIMEDS PHARMACEUTICALS US INC	$26.91M	-139.60%	-102.80%	-61.93%	-990.20%	0.13	8.34	N/A	N/A	N/A
IMCC	IM CANNABIS CORP	$7.60M	-86.70%	-9.20%	51.83%	26.60%	10.10	0.82	23.50%	-7.50%	5.81%
RDHL	REDHILL BIOPHARMA LTD	$0.00	N/A	-46.10%	269.50%	86.10%	-5.17	0.56	64.50%	-97.50%	-110.40%
SNOA	SONOMA PHARMACEUTICALS INC	$6.11M	-81.30%	-24.90%	-35.87%	-58.90%	2.66	2.89	37.70%	-20.50%	-20.19%
SXTC	CHINA SXT PHARMACEUTICALS INC	$19.41M	-22.50%	-14.80%	-16.97%	-162.40%	0.40	3.54	32,034.00%	-76,811.30%	-61,739.85%
PRFX	PAINREFORM LTD	$1.95M	-127.60%	-57.30%	-47.45%	129.70%	0.32	1.59	N/A	N/A	N/A
BGM	BGM GROUP LTD	$39.24M	-2.40%	-2.10%	-3.78%	-20.90%	0.13	1.82	19.40%	-10.10%	-25.89%
TXMD	THERAPEUTICSMD INC	$20.26M	1.10%	0.80%	0.71%	0.80%	0.41	2.93	100.00%	10.80%	8.51%
AVDL	AVADEL PHARMACEUTICALS PLC	$2.09B	-0.30%	-0.20%	4.71%	7.80%	1.03	2.76	94.90%	-0.10%	2.60%
UPC	UNIVERSE PHARMACEUTICALS INC	$2.24M	2.70%	1.70%	2.27%	5.90%	0.46	2.78	30.40%	5.60%	6.74%
SBFM	SUNSHINE BIOPHARMA INC	$6.57M	-24.90%	-19.50%	-26.17%	-47.80%	0.30	4.21	33.00%	-16.10%	-17.41%
IXHL	INCANNEX HEALTHCARE INC	$146.45M	-193.90%	-151.40%	-61.72%	-1,337.00%	0.02	47.51	100.00%	-398,933.30%	-396,408.33%
INCR	INTERCURE LTD	$62.25M	-15.90%	-9.50%	-6.43%	-8.00%	0.74	1.85	11.40%	-29.20%	-14.54%
BFRI	BIOFRONTERA INC	$9.46M	N/A	-94.70%	-600.17%	-238.90%	-6.97	1.15	64.40%	-47.30%	-46.22%
CPHI	CHINA PHARMA HOLDINGS INC	$7.80M	-43.30%	-21.70%	-33.55%	-60.60%	0.90	0.35	-10.90%	-78.70%	-76.02%
CPIX	CUMBERLAND PHARMACEUTICALS INC	$37.84M	-12.60%	-4.80%	-6.64%	-12.10%	1.54	1.23	84.50%	-8.10%	-6.69%
AYTU	AYTU BIOPHARMA INC	$23.43M	-48.50%	-10.70%	-16.64%	-142.30%	4.39	1.23	67.60%	-20.50%	-15.41%
CABR	CARING BRANDS INC	$16.95M	N/A	N/A	N/A	N/A	0.22	0.08	N/A	N/A	N/A
EVOK	EVOKE PHARMA INC	$18.86M	-101.40%	-31.90%	-138.65%	225.10%	3.65	1.27	97.00%	-36.20%	-32.76%
YCBD	CBDMD INC	$10.70M	-184.40%	-45.20%	-24.47%	-253.70%	0.62	N/A	61.20%	-25.50%	-8.12%
GELS	GELTEQ LTD	$10.82M	-43.00%	-31.50%	-29.63%	-7,184.60%	0.36	0.27	30.30%	-4,011.90%	-2,834.31%

Pharmaceutical Stocks FAQ

What are the best pharmaceutical stocks to buy right now in Dec 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best pharma stocks to buy right now are:

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the #1 top pharmaceutical stock out of 78 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Ironwood Pharmaceuticals (NASDAQ:IRWD) is: Value: A, Growth: B, Momentum: B, Sentiment: C, Safety: C, Financials: A, and AI: A.

Ironwood Pharmaceuticals (NASDAQ:IRWD) has a Due Diligence Score of 35, which is 7 points higher than the pharmaceutical industry average of 28.

IRWD passed 11 out of 33 due diligence checks and has average fundamentals. Ironwood Pharmaceuticals has seen its stock return 0.56% over the past year, overperforming other pharmaceutical stocks by 7 percentage points.

Ironwood Pharmaceuticals has an average 1 year price target of $3.00, a downside of -16.2% from Ironwood Pharmaceuticals's current stock price of $3.58.

Ironwood Pharmaceuticals stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Ironwood Pharmaceuticals, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Collegium Pharmaceutical (NASDAQ:COLL)

Collegium Pharmaceutical (NASDAQ:COLL) is the #2 top pharmaceutical stock out of 78 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Collegium Pharmaceutical (NASDAQ:COLL) is: Value: A, Growth: B, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: A.

Collegium Pharmaceutical (NASDAQ:COLL) has a Due Diligence Score of 49, which is 21 points higher than the pharmaceutical industry average of 28.

COLL passed 17 out of 33 due diligence checks and has strong fundamentals. Collegium Pharmaceutical has seen its stock return 61.62% over the past year, overperforming other pharmaceutical stocks by 68 percentage points.

Collegium Pharmaceutical has an average 1 year price target of $49.50, an upside of 1.79% from Collegium Pharmaceutical's current stock price of $48.63.

Collegium Pharmaceutical stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Collegium Pharmaceutical, 50% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Indivior (NASDAQ:INDV)

Indivior (NASDAQ:INDV) is the #3 top pharmaceutical stock out of 78 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Indivior (NASDAQ:INDV) is: Value: B, Growth: B, Momentum: B, Sentiment: B, Safety: B, Financials: B, and AI: C.

Indivior (NASDAQ:INDV) has a Due Diligence Score of 33, which is 5 points higher than the pharmaceutical industry average of 28.

INDV passed 10 out of 33 due diligence checks and has average fundamentals. Indivior has seen its stock return 209.22% over the past year, overperforming other pharmaceutical stocks by 215 percentage points.

Indivior has an average 1 year price target of $32.50, a downside of -8.61% from Indivior's current stock price of $35.56.

Indivior stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Indivior, 50% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the pharmaceutical stocks with highest dividends?

Out of 6 pharmaceutical stocks that have issued dividends in the past year, the 3 pharmaceutical stocks with the highest dividend yields are:

1. Perrigo Co (NYSE:PRGO)

Perrigo Co (NYSE:PRGO) has an annual dividend yield of 4.41%, which is 2 percentage points higher than the pharmaceutical industry average of 2.3%. Perrigo Co's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Perrigo Co's dividend has shown consistent growth over the last 10 years.

Perrigo Co's dividend payout ratio of -301.6% indicates that its high dividend yield might not be sustainable for the long-term.

2. Viatris (NASDAQ:VTRS)

Viatris (NASDAQ:VTRS) has an annual dividend yield of 4.12%, which is 2 percentage points higher than the pharmaceutical industry average of 2.3%. Viatris's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Viatris's dividend has shown consistent growth over the last 10 years.

Viatris's dividend payout ratio of -15.5% indicates that its high dividend yield might not be sustainable for the long-term.

3. Kamada (NASDAQ:KMDA)

Kamada (NASDAQ:KMDA) has an annual dividend yield of 2.85%, which is 1 percentage points higher than the pharmaceutical industry average of 2.3%.

Kamada's dividend payout ratio of 57.1% indicates that its dividend yield is sustainable for the long-term.

Why are pharmaceutical stocks down?

Pharmaceutical stocks were down -0.05% in the last day, and up 0.96% over the last week.

We couldn't find a catalyst for why pharmaceutical stocks are down.

What are the most undervalued pharmaceutical stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued pharmaceutical stocks right now are:

1. Bausch Health Companies (NYSE:BHC)

Bausch Health Companies (NYSE:BHC) is the most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Bausch Health Companies has a valuation score of 57, which is 35 points higher than the pharmaceutical industry average of 22. It passed 4 out of 7 valuation due diligence checks.

Bausch Health Companies's stock has dropped -10.71% in the past year. It has underperformed other stocks in the pharmaceutical industry by -5 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 57, which is 35 points higher than the pharmaceutical industry average of 22. It passed 4 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 0.56% in the past year. It has overperformed other stocks in the pharmaceutical industry by 7 percentage points.

3. Alkermes (NASDAQ:ALKS)

Alkermes (NASDAQ:ALKS) is the third most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Alkermes has a valuation score of 57, which is 35 points higher than the pharmaceutical industry average of 22. It passed 4 out of 7 valuation due diligence checks.

Alkermes's stock has dropped -6.56% in the past year. It has performed in line with other stocks in the pharmaceutical industry.

Are pharmaceutical stocks a good buy now?

52.38% of pharmaceutical stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical stocks to rise by 52.29% over the next year.

27.27% of pharmaceutical stocks have a Zen Rating of A (Strong Buy), 9.09% of pharmaceutical stocks are rated B (Buy), 47.27% are rated C (Hold), 12.73% are rated D (Sell), and 3.64% are rated F (Strong Sell).

What is the average p/e ratio of the drug manufacturers - specialty & generic industry?

The average P/E ratio of the drug manufacturers - specialty & generic industry is -1.56x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.